| PE25.06 | PrEP adherence is associated with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe | E-poster | Product acceptability and adherence |
| PE01.34 | Preferences for PrEP formulations and service delivery: results from qualitative in-depth interviews with transgender women in three South African cities | E-poster | Behavioural and social science research |
| PE08.01 | Preferences for implantable pre-exposure prophylaxis products among adolescent girls, young women, and female sex workers in South Africa | E-poster | Delivery technologies: novel approaches, formulation and multi-purpose |
| PE16.20 | Pre-exposure prophylaxis (PrEP) uptake and adherence in gays, bisexuals and transgender women (GBT): qualitative insights from PrEP users, providers and GBT leadership in coastal Kenya | E-poster | Implementation science, including structural interventions, PrEP & VMMC |
| PE25.09 | Predictors of PrEP discontinuation and refill delays among over 47,000 clients first starting PrEP in Kenya, Lesotho and Tanzania: Implications for programs | E-poster | Product acceptability and adherence |
| PE18.02 | Predicting PrEP efficacy in women with partial adherence to tenofovir disoproxil fumarate/emtricitabine | E-poster | Mathematical modelling: impact and effectiveness |
| PE02.10 | Precursor frequencies of naïve B cells targeting HIV candidate immunogens | E-poster | Broadly neutralizing antibodies |
| PU06.02 | Post-randomization differences in condomless vaginal sex among women randomized to DMPA-IM, copper IUD and levonorgestrel implant in the ECHO trial | Publication Only | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| PU01.02 | Post exposure prophylaxis for HIV infection after sexual assault: understanding the trend of uptake in a Nigerian tertiary healthcare Institution | Publication Only | Behavioural and social science research |
| PE19.01 | Population-level correlation between incidence of selected sexually transmitted infections and HIV-1 among women participating in HIV pre-exposure prophylaxis trials in Africa | E-poster | Microbiome & STI: impact on prevention |